Canada markets closed
  • S&P/TSX

    19,991.88
    +105.94 (+0.53%)
     
  • S&P 500

    4,207.27
    -2.97 (-0.07%)
     
  • DOW

    33,336.67
    +27.16 (+0.08%)
     
  • CAD/USD

    0.7836
    +0.0007 (+0.09%)
     
  • CRUDE OIL

    93.99
    +2.06 (+2.24%)
     
  • BTC-CAD

    30,871.32
    +283.75 (+0.93%)
     
  • CMC Crypto 200

    573.13
    -1.61 (-0.28%)
     
  • GOLD FUTURES

    1,805.50
    -8.20 (-0.45%)
     
  • RUSSELL 2000

    1,975.26
    +6.01 (+0.31%)
     
  • 10-Yr Bond

    2.8880
    +0.1020 (+3.66%)
     
  • NASDAQ futures

    13,346.75
    -45.25 (-0.34%)
     
  • VOLATILITY

    20.20
    +0.46 (+2.33%)
     
  • FTSE

    7,465.91
    -41.20 (-0.55%)
     
  • NIKKEI 225

    27,819.33
    -180.63 (-0.65%)
     
  • CAD/EUR

    0.7589
    -0.0008 (-0.11%)
     

Is Aurora Cannabis Too Cheap to Pass Up Right Now?

·4 min read
Is Aurora Cannabis Too Cheap to Pass Up Right Now?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Aurora Cannabis (NASDAQ: ACB) is one of the most beaten-down cannabis stocks in the entire industry. Investors will recall that back in 2018, Aurora announced it was acquiring medical marijuana company MedReleaf for more than $2.5 billion in what at the time was the sector's largest deal. Today, Aurora is worth about one-fifth of that value, with a market cap of over $400 million.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting